IIM
CRDF icon

INTECH Investment Management’s Cardiff Oncology CRDF Stock Holding History

INTECH Investment Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,546
Closed -$26.8K – 2137
2026
Q1 		$26.8K Sell
16,546
-11,445
-41% -$23.5K ﹤0.01% 2055
2025
Q4 		$78.7K Hold
27,991
– – ﹤0.01% 2200
2025
Q3 		$57.7K Sell
27,991
-1,804
-6% -$4.99K ﹤0.01% 2357
2025
Q2 		$93.9K Sell
29,795
-1,279
-4% -$3.9K ﹤0.01% 2313
2025
Q1 		$97.6K Buy
31,074
+12,808
+70% +$50.6K ﹤0.01% 2318
2024
Q4 		$79.3K Buy
+18,266
New +$57.1K ﹤0.01% 2260

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

INTECH Investment Management's CRDF Position: Q2 2026 in Review

INTECH Investment Management sold out of Cardiff Oncology (CRDF) in Q2 2026, closing a stake of 16,546 shares — an estimated $26.8K sold.

INTECH Investment Management first reported a position in CRDF in Q4 2024 and held it in 6 quarters. The position peaked at $97.6K in Q1 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • INTECH Investment Management reported no remaining Cardiff Oncology position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 16,546 Cardiff Oncology shares in Q2 2026, an estimated $26.8K.
  • INTECH Investment Management first reported a position in Cardiff Oncology in Q4 2024 and held it in 6 quarters.
  • INTECH Investment Management's Cardiff Oncology position peaked at $97.6K in Q1 2025.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.